|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical and virological differences between hepatitis B virus genotypes B and C:a case-control study显示文摘 | Tangkijvanich P Mahachai V Komolmit P | 2004 | Med Assoc Thai2004，87，2： | 1 |
| 2 | Comparison between quantitative hepatitis B surface antigen, hepatitis B eantigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-a-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B 显示文摘 | Tangkijvanich P Komolmit P Mahachai V Sa-Nguanmoo P Theamboonlers A Poovorawan Y | 2010 | Heoatol Res2010，40，4： | 1 |
| 3 | Comparison between quantitative hepatitis B surface antigen,hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferonα-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B显示文摘 | Tangkijvanich P Komolmit P Mahachai V Sa-Nguanmoo P Theamboonlers A Poovorawan Y | | Hepatology Research0，，： | 1 |
| 4 | Comparisonbetween quantitative hepatitis B surface antigen, hepatitis B eantigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-alpha-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B 显示文摘 | Tangkijvanich P Komolmit P Mahachai V | 2010 | Hepatol Res2010，40，4： | 1 |
| 5 | Co- mparison between quantitative hepatitis B surface an- tigen,hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-alpha-2b therapy in hepatitis P, e-antigen- positive chronic hepatitis B显示文摘 | Tangkijvanich P Komolmit P Mahachai V | 2010 | Hepatol Res2010，40，4： | 1 |
| 6 | Compar-ison between quantitative hepatitis B surface antigen,hep-atitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B显示文摘 | Tangkijvanich P Komolmit P Mahachai V | | 0，，03： | 1 |
| 7 | Com- parison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-a- 2b therapy in hepatitis B e-antigen-positive chronic hep- atitis B 显示文摘 | Tangkijvanich P Komolmit P MahachaiV et al | 2010 | Hepatol Res2010，40，4： | 1 |
| 8 | Comparison between quantitative hepatitis B surface antigen,hepatitis B eantigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-alpha-2btherapy in hepatitis B e-antigen-positive chronic hepatitis B显示文摘 | Tangki jvanich P Komolmit P Mahachai V | 2010 | Hepatol Res2010，40，4： | 1 |
| 9 | He- patic cytochrome p450 2el activity in nonalcoholic fatty liver disease显示文摘 | Prompila N Wittayalertpanya S Komolmit P | 2008 | J Med Assoc Thai2008，91，5： | 1 |
| 10 | Low pretreatment serum HBsAg level and viral mutations as predic- tors of response to PEG -interferon alpha -2b therapy in chron- ic hepatitis B显示文摘 | TANGKIJVANICH P KOMOLMIT P MAHACHAI V | 2009 | J Clin Virol2009，46，2： | 1 |
| 11 | Comparison be- tween quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitisB virus DNA levels for predicting virological response to pegylated tnterferon-alpha-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B显示文摘 | Tangkijvanich P Komolmit P Mahachai V | 2010 | Hepatol Res2010，40，4： | 1 |
| 12 | Intrahepatic HBV DNA and covalently closed circular DNA (cecDNA) levels in patients positive for anti-HBc and negative for HBsAg显示文摘 | Chaiteerakij R Komolmit P Sa-nguanmoo P | 2010 | Southeast Asian J Trop Med Public Health2010，41，4： | 1 |
| 13 | Comparison between quantitative hepatitis B surface antigen,hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B显示文摘 | Tangkijvanich P Komolmit P Mahachai V | 2010 | Hepatol Res2010，40，3： | 1 |
| 14 | Intrahepatic HBV DNA and covalently closed circular DNA(cccDNA) levels in patients positive for anti-HBc and negativefor HBsAg 显示文摘 | Chaiteerakij R Komolmit p Sa-nguanmoop | 2010 | Southeast Asian J Trop Med Public Health2010，41，4： | 1 |
| 15 | Comparison betweenquantitative hepatitis surface antigen ,hepatitis B e antigen and hepatitis B virus DNA levels for predicting virological response to pegylated inter- feron alfa-2b therapy in hepatitis B e-antigen positive chronic hepatitis B显示文摘 | Tangkijvanich P Komolmit P Mahachai V | 2010 | Hepatol Res2010，40，4： | 1 |
| 16 | 52-week efficacyand safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B 显示文摘 | Piratvisuth T Komolmit P Tanwandee T | 2013 | PLoS Orre2013，8，54： | 1 |
| 17 | Comparison between quantitative hepatitis B surface antigen,hepatitis B e-antigen and hepatitis B virus DNA levels for predicting viro-logical response to pegylated interferon-alpha-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B显示文摘 | Tangkijvanich P Komolmit P Mahachai V | | 0，，04： | 1 |
| 18 | Hepatitis B virus geno2 types and hepatocellular carcinoma in Thailand 显示文摘 | Tangkijvanich P Mahachai V komolmit P | 2005 | World J Gastoen2 terol2005，11，15： | 1 |
| 19 | Taerolimus in liver transplantation 显示文摘 | Komolmit P Davies MH | 1999 | Expert Opin Investig Drugs1999，8，8： | 1 |
| 20 | Comparison between quantitative hepatitis B surface antigen,hepatitis B e-antigen and hepatitis B virus DNA levels for predicting vi-rological response to pegylated interferon-alpha-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B显示文摘 | Tangkijvanich P Komolmit P Mahachai V | | 0，，04： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员